FNY:NASDAQFirst Trust Mid Cap Growth AlphaDEX Fund Analysis

The fund is trading at $107.94, comfortably above its 20‑day ($104.54), 50‑day ($101.94) and 200‑day ($95.18) simple moving averages, indicating a strong bullish momentum. RSI sits at 62.2, still in the upper‑mid range but not yet overbought, while the MACD line (1.39) exceeds its signal (1.18) producing a bullish histogram (+0.22). Volume is on an upward trend, reinforcing the price advance, and the market is in an Extreme Greed phase (Fear & Greed Index 91). The price is holding above the identified support of $100.18 and is approaching the resistance at $108.09, suggesting a near‑term upside target. YTD performance of +14.9% outpaces many peers, though the expense ratio of 0.73% is modest for an active‑style ETF.
Risk considerations include a beta of 1.39, implying higher sensitivity to market swings, and a 30‑day volatility of ~24.6%, which could amplify short‑term swings. The maximum drawdown of -12% is acceptable but warrants caution. Liquidity appears moderate; while the 10‑day average volume is ~29,600 shares, today’s volume was only 6,369, indicating potential execution challenges in rapid moves. Tracking error is effectively zero, and there is no premium/discount, reducing tracking risk. Sector concentration is typical for a mid‑cap growth focus, presenting a medium‑level exposure risk.